These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32857767)

  • 1. fosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates.
    Singkham-In U; Muhummudaree N; Chatsuwan T
    PLoS One; 2020; 15(8):e0237474. PubMed ID: 32857767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.
    Chen J; Wang D; Ding Y; Zhang L; Li X
    Microb Drug Resist; 2019 Mar; 25(2):251-257. PubMed ID: 30113251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China.
    Jiang Y; Shen P; Wei Z; Liu L; He F; Shi K; Wang Y; Wang H; Yu Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):66-70. PubMed ID: 25450805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China.
    Huang L; Cao M; Hu Y; Zhang R; Xiao Y; Chen G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106226. PubMed ID: 33212165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Sequence of a Novel IncR-F33:A-:B- Plasmid, pKP1034, Harboring fosA3, blaKPC-2, blaCTX-M-65, blaSHV-12, and rmtB from an Epidemic Klebsiella pneumoniae Sequence Type 11 Strain in China.
    Xiang DR; Li JJ; Sheng ZK; Yu HY; Deng M; Bi S; Hu FS; Chen W; Xue XW; Zhou ZB; Doi Y; Sheng JF; Li LJ
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1343-8. PubMed ID: 26666939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates.
    Lu PL; Hsieh YJ; Lin JE; Huang JW; Yang TY; Lin L; Tseng SP
    Int J Antimicrob Agents; 2016 Nov; 48(5):564-568. PubMed ID: 27765412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.
    Tseng SP; Wang SF; Ma L; Wang TY; Yang TY; Siu LK; Chuang YC; Lee PS; Wang JT; Wu TL; Lin JC; Lu PL
    J Microbiol Immunol Infect; 2017 Oct; 50(5):653-661. PubMed ID: 28705769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Detection of
    Nigiz Ş; Hazırolan G; Köseoglu Eser Ö; Gür D
    Microb Drug Resist; 2022 Mar; 28(3):317-321. PubMed ID: 34851744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a Multidrug-Resistant Porcine Klebsiella pneumoniae Sequence Type 11 Strain Coharboring
    Zhang W; Zhu Y; Wang C; Liu W; Li R; Chen F; Luan T; Zhang Y; Schwarz S; Liu S
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31511369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Plasmid Vectors Mediate the Spread of
    Lv L; Huang X; Wang J; Huang Y; Gao X; Liu Y; Zhou Q; Zhang Q; Yang J; Guo JY; Liu JH
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.
    Liu P; Chen S; Wu ZY; Qi M; Li XY; Liu CX
    J Glob Antimicrob Resist; 2020 Sep; 22():238-243. PubMed ID: 32061879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
    de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
    J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.